Eli Lilly and Company (NYSE: LLY)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 1153.18 (-2.09 / -0.18%) | 1,148.52 (-6.45 / -0.56%) | 1,149.10 (+0.58 / +0.05%) |
| 31-Jul 09:20 | 31-Jul 15:59 | 31-Jul 19:04 |
Sector: Healthcare || Industry: Drug Manufacturers - General
| Previous Close | 1154.97 | Year Low | 623.78 |
| Open | 1148.51 | Year High | 1249.45 |
| Day Low | 1119.00 | Price Avg 50 | 1144.77 |
| Day High | 1150.63 | Price Avg 200 | 1023.15 |
| Volume | 2.29 M | Market Cap | 1.08 T |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| LLY | -0.56 | -3.84 | -4.24 | 22.89 | 10.74 | 55.19 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2026 | BMO | LLY | Eli Lilly | Q1 2026 | EPS | 6.66 | 8.55 | 28.38 | 3.34 | 156.00 | |
| 04/30/2026 | BMO | LLY | Eli Lilly | Q1 2026 | REV | 17.62 B | 19.80 B | 12.40 | 12.73 B | 55.54 | |
| 02/04/2026 | BMO | LLY | Eli Lilly and Co | Q4 2025 | EPS | 6.67 | 7.54 | 13.04 | 5.32 | 41.70 | |
| 02/04/2026 | BMO | LLY | Eli Lilly and Co | Q4 2025 | REV | 17.96 B | 19.30 B | 7.47 | 13.53 B | 42.65 | |
| 10/30/2025 | BMO | LLY | Eli Lilly | Q3 2025 | EPS | 5.70 | 7.02 | 23.16 | 1.18 | 494.90 | |
| 10/30/2025 | BMO | LLY | Eli Lilly | Q3 2025 | REV | 16.02 B | 17.60 B | 9.90 | 11.44 B | 53.87 | |
| 08/07/2025 | BMO | LLY | Eli Lilly | Q2 2025 | EPS | 6.07 | 6.31 | 3.95 | 3.92 | 61.00 | |
| 08/07/2025 | BMO | LLY | Eli Lilly | Q2 2025 | REV | 15.42 B | 15.56 B | 0.91 | 11.30 B | 37.64 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/04/2026 | 06:45 AM | LLY | Eli Lilly and Co | FY 2026 | EPS | $33.23 | $33.50 ~ $35.00 | 0.00 | 34.25 | 3.07 | 43,113 | ||||||||||||
| 02/04/2026 | 06:45 AM | LLY | Eli Lilly and Co | FY 2026 | REV | $77.62 B | $80.00 B ~ $83.00 B | 0.00 | 81,500.00 | 5.00 | 43,113 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 06/25/2026 | LLY | Leerink Partners | Outperform | Outperform | Maintain |
| 06/09/2026 | LLY | Jefferies | Buy | Buy | Maintain |
| 05/26/2026 | LLY | B of A Securities | Buy | Buy | Maintain |
| 05/05/2026 | LLY | Guggenheim | Buy | Buy | Maintain |
| 05/05/2026 | LLY | Barclays | Overweight | Overweight | Maintain |
| 05/04/2026 | LLY | Wolfe Research | Outperform | Outperform | Maintain |
| 05/01/2026 | LLY | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 04/22/2026 | LLY | Guggenheim | Buy | Buy | Maintain |
| 04/10/2026 | LLY | Morgan Stanley | Overweight | Overweight | Maintain |
| 04/02/2026 | LLY | B of A Securities | Buy | Buy | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|---|---|---|---|---|---|---|---|---|
| 06/22/2026 | LLY | Eli Lilly | Quarterly | 1.73 | 0.01 | 08/14/2026 | 08/14/2026 | 09/10/2026 | Increased |
| 05/04/2026 | LLY | Eli Lilly | Quarterly | 1.73 | 0.01 | 05/15/2026 | 05/15/2026 | 06/10/2026 | Increased |
| 12/08/2025 | LLY | Eli Lilly and Co | Quarterly | 1.73 | 0.01 | 02/13/2026 | 02/13/2026 | 03/10/2026 | Increased |
| 10/27/2025 | LLY | Eli Lilly | Quarterly | 1.50 | 0.01 | 11/14/2025 | 11/14/2025 | 12/10/2025 | Increased |
Sign-Up to see the full list of CATALYSTS in the Calendars
